A Doctor of Philosophy (PhD) student in the Department of Chemistry, University of Ilorin, Misitura Lawal-Arowona, has developed a drug that promises to be potent in the treatment of tuberculosis (TB), an infectious disease that usually attacks the lungs.

The student, who is being supervised by Prof. Joshua Obaleye, is currently undergoing a sandwich fellowship at the Faculty of Science of The Maharaja Sayajirao University (MSU), Baroda in India.

According to a report published in the Sunday Times of India, the metal attached anti-TB drug developed by Mrs. Arowona, who is a Lecturer at the Kebbi State University of Science and Technology, Aliero in Kebbi State, has improved the efficiency of the anti-TB drugs compared to normal drugs that are consumed globally.

Nigeria is among the 14 high burden countries for TB, TB/HIV and multi-drug resistant TB. The country is ranked seventh among the 30 high TB burden countries and second in Africa.

The problem of TB in Nigeria has been made worse by the issues of drug resistant TB and the HIV/AIDS epidemic. It is estimated that about 407,000 people in Nigeria have TB in a year.

In an interview with the Indian newspaper, Mrs...

Read the full story here:

https:///paLLz4-1ji